Tandem Diabetes Care, Inc., Tandem Diabetes Care Europe B.V., v. Respondent

1

Hamburg – Local Division

UPC_CFI_88/2024

Preliminary Order

of the Court of First Instance of the Unified Patent Court

Issued: 09/09/2024

PARTIES:

Roche Diabetes Care GmbH, represented by Herrn Götzl, Sandhofer Straße 116, 68305 Mannheim,

Germany,

Plaintiff and Counterdefendant 1)

represented by:

Kather Augenstein Rechtsanwälte PartGmbB, Dr. Christof

Augenstein, Sophie Prudent, LL.M., Dr. Katharina Brandt,

Rechtsanwalt Knaps, Bahnstraße 16, 40212 Düsseldorf

augenstein@katheraugenstein.com

prudent@katheraugenstein.com

brandt@katheraugenstein.com knaps@katheraugenstein.com

F. Hoffmann-La Roche AG, Grenzacherstraße 124, 4058 Basel, Switzerland,

Counterdefendant 2)

represented by:

Kather Augenstein Rechtsanwälte PartGmbB, Dr. Christof

Augenstein, Sophie Prudent, LL.M., Dr. Katharina Brandt,

Rechtsanwalt Knaps, Bahnstraße 16, 40212 Düsseldorf

augenstein@katheraugenstein.com

prudent@katheraugenstein.com

brandt@katheraugenstein.com knaps@katheraugenstein.com

and

1.

Tandem Diabetes Care, Inc., represented by its legal representative, 12400 High Bluff

Drive, CA 92130, San Diego, United States of America,

Defendant 1)

2

2.

Tandem Diabetes Care Europe B.V., .represented by its legal representative, Schiphol Boulevard

359, WTC Schiphol Airport, D-Tower 11th floor, 1118 BJ, Schiphol, Netherland,

Defendant 2)

3.

VitalAire GmbH, represented by its legal representative, von Bornbarch 2, 22848 Norderstedt,

Deutschland

Defendant 3) and Counterclaimant

Defendant 1) und 2) represented by: Taylor Wessing N.V., Charlotte Garnitsch (111867/2023), Dr. Wim

Maas (112021/2023), Iris van der Heijdt, Pauline Springorum,

Kennedyplein 201, 5611 ZT Eindhoven, NL,

c.garnitsch@taylorwessing.com

w.maas@taylorwessing.com

Defendant 3) represented by:

Hoyng Rokh Monegier, Dr. Christine Kanz, Steinstraße 20,

40212 Düsseldorf,

christine.kanz@hoyngrokh.com

Patent at issue

Patent no.

Proprietor

EP2196231

Roche Diabetes Care GmbH, F.Hoffmann-La Roche AG

Deciding Judges:

This order is issued by

Presiding Judge and Judge Rapporteur Sabine Klepsch

Legally qualified judge Dr. Stefan Schilling

Legally qualified Judge Dr. Tatyana Zhilova

Technically qualified Judge Giorgio Checcacci

Language of Proceedings:

English

Subject-Matter of the Proceedings:

Patent infringement

Request to stay proceedings

Statement of the forms of order sought by the parties:

The requesting parties, defendants 1) and 2), with the consent of the defendant 3), are

requesting:

3

I.

to stay the infringement action with Ref. 10800/2024 (the ‘Infringement Action’)

pursuant to Rules 295(f) and (m), 75 and 37(4) of the Rules of Procedure and Articles

33(5) and 33(3)(b) UPCA

II.

in the meantime, based on Rule 295(m) in conjunction with Rule 9 of the Rules of

Procedure to stay the infringement proceedings until the court has ruled on Request I.

The respondent, claimant, is requesting:

1.

Dismissal of the defendants‘ application for stay of the present proceedings,

2.

to decide, pursuant to Rule 37.2 of the Rules of Procedure, to hear the proceedings

under Art. 33(3) UPCA together before the Local Division Hamburg.

of Facts:

The Claimant alleges infringement of European Patent 2 196 231 by the defendants‘ t:slim X2

insulin pump with the interchangeable t:slim X2 reservoir (attacked embodiment). Defendant 1) is

a US manufacturer of medical devices based in San Diego, California. The company develops

medical technologies for the treatment of diabetes and in particular for insulin infusion therapy.

Its products include insulin pumps, such as the t:slim X2 insulin pump. Defendant 2) is the

importer and operates the Dutch distribution centre of Defendant 1) for Europe. Defendant 3) is a

German healthcare company with its headquarters in Norderstedt. It offers holistic solutions and

concepts for home therapy. In particular, it distributes insulin therapy produ